Compounds > zidovudine
Page last updated: 2024-08-23

zidovudine and Koch's Disease

zidovudine has been researched along with Koch's Disease in 20 studies

Research

Studies (20)

TimeframeStudies, this research(%)All Research%
pre-19901 (5.00)18.7374
1990's10 (50.00)18.2507
2000's3 (15.00)29.6817
2010's6 (30.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Froeyen, M; Helynck, O; Munier-Lehmann, H; Van Calenbergh, S; Van Poecke, S1
Alexandrova, L; Andreevskaya, S; Chernousova, L; Khandazhinskaya, A; Kochetkov, S; Margolis, L; Matyugina, E; Smirnova, T; Vanpouille, C; Zicari, S1
Chaisson, RE; Cohn, S; Dooley, KE; Hoffmann, C; Hoffmann, J; Lala, S; Martinson, N; Mashabela, F; Salazar-Austin, N; Waja, Z1
Aris, E; Baernighausen, T; Chalamilla, G; Fawzi, W; Hertzmark, E; Jackson, E; Machumi, L; Muya, A; Mwanyika-Sando, M; Sando, D; Spiegelman, D1
Aklillu, E; Bisaso, RK; Gustafsson, LL; Mukonzo, JK; Ogwal-Okeng, J; Owen, JS1
Boamah, I; Court, MH; Kashuba, AD; Kenu, E; Kwara, A; Lartey, M; Oliver-Commey, J; Rezk, NL1
Bartlett, JA; Crump, JA; Kiwera, RA; Moon, AM; Ole-Nguyaine, S; Ramadhani, HO; Shao, HJ; Shao, JF; Thielman, NM; Uiso, LO; Woods, CW1
Brown, LB; Eron, JJ; Hosseinipour, MC; Kumwenda, JJ; Mhango, B; Mzinganjira, D; Phiri, S; van Oosterhout, JJ; Weigel, R1
Bednarsh, H; Jorge, J; McCarthy, GM; Page-Shafer, K; Ssali, CS; Wangrangsimakul, K1
Galeano Jiménez, AH1
Beijnen, JH; Burger, DM; Koks, CH; Meenhorst, PL1
Bradbeer, CS; Griffin, GE; Lau, R; O'Farrell, N; Pozniak, AL; Yoganathan, K1
Briceland, LL; Cleary, JD; Fletcher, CV; Healy, DP; Peloquin, CA1
Brown, JW1
Brigido, LF; Casseb, JR; Duarte, AJ; Fonseca, LA; Reingold, AL1
James, JS1
Lumio, J1
Antoniskis, D; Barnes, PF; Davidson, PT; Easley, AC; Espina, BM1
Colley, J; Feingold, AR; Iezza, A; Satyadeo, M; Selwyn, PA; Shaw, JF; Torres, R1

Reviews

3 review(s) available for zidovudine and Koch's Disease

ArticleYear
Transmission of HIV in the dental clinic and elsewhere.
    Oral diseases, 2002, Volume: 8 Suppl 2

    Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Breast Feeding; Cross Infection; Dental Clinics; Developed Countries; Developing Countries; Female; HIV Infections; Humans; Infant; Infection Control, Dental; Infectious Disease Transmission, Patient-to-Professional; Infectious Disease Transmission, Professional-to-Patient; Infectious Disease Transmission, Vertical; Occupational Diseases; Occupational Exposure; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Risk Factors; Sexual Behavior; Tuberculosis; Zidovudine

2002
Recent advances: antiinfectives.
    The Annals of pharmacotherapy, 1995, Volume: 29, Issue:10

    Topics: Acquired Immunodeficiency Syndrome; Adjuvants, Immunologic; Anti-Bacterial Agents; Antiviral Agents; Drug Resistance, Microbial; Humans; Peptic Ulcer; Streptococcus; Tuberculosis; Zidovudine

1995
[Treatment and prevention of HIV infection and related opportunistic infections].
    Duodecim; laaketieteellinen aikakauskirja, 1992, Volume: 108, Issue:5

    Topics: AIDS-Related Opportunistic Infections; Cryptococcosis; Cytomegalovirus Infections; Female; Herpesviridae Infections; HIV Infections; Humans; Male; Mycobacterium avium-intracellulare Infection; Pneumocystis Infections; Toxoplasmosis; Tuberculosis; Zidovudine

1992

Trials

2 trial(s) available for zidovudine and Koch's Disease

ArticleYear
Interindividual variability in pharmacokinetics of generic nucleoside reverse transcriptase inhibitors in TB/HIV-coinfected Ghanaian patients: UGT2B7*1c is associated with faster zidovudine clearance and glucuronidation.
    Journal of clinical pharmacology, 2009, Volume: 49, Issue:9

    Topics: Adult; AIDS-Related Opportunistic Infections; Drug Combinations; Drug Therapy, Combination; Drugs, Generic; Female; Ghana; Glucuronides; Glucuronosyltransferase; Half-Life; HIV Infections; Humans; Lamivudine; Liver; Male; Middle Aged; Polymorphism, Genetic; Reverse Transcriptase Inhibitors; Stavudine; Tuberculosis; Zidovudine

2009
Early versus delayed fixed dose combination abacavir/lamivudine/zidovudine in patients with HIV and tuberculosis in Tanzania.
    AIDS research and human retroviruses, 2009, Volume: 25, Issue:12

    Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Dideoxynucleosides; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Immune Reconstitution Inflammatory Syndrome; Lamivudine; Male; Pilot Projects; Tanzania; Tuberculosis; Viral Load; Zidovudine

2009

Other Studies

15 other study(ies) available for zidovudine and Koch's Disease

ArticleYear
Synthesis and inhibitory activity of thymidine analogues targeting Mycobacterium tuberculosis thymidine monophosphate kinase.
    Bioorganic & medicinal chemistry, 2011, Dec-15, Volume: 19, Issue:24

    Topics: Humans; Models, Molecular; Mycobacterium tuberculosis; Nucleoside-Phosphate Kinase; Protein Kinase Inhibitors; Thymidine; Thymidine Monophosphate; Tuberculosis

2011
Dual-targeted anti-TB/anti-HIV heterodimers.
    Antiviral research, 2017, Volume: 145

    Topics: Antitubercular Agents; Cell Culture Techniques; Cells, Cultured; Drug Design; Drug Resistance, Multiple, Bacterial; HIV Infections; HIV-1; Humans; Lymphocytes; Mycobacterium tuberculosis; Tuberculosis; Virus Replication; Zidovudine

2017
Poor Obstetric and Infant Outcomes in Human Immunodeficiency Virus-Infected Pregnant Women With Tuberculosis in South Africa: The Tshepiso Study.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2018, 03-05, Volume: 66, Issue:6

    Topics: Adolescent; Adult; Anti-HIV Agents; Antitubercular Agents; Female; Gestational Age; HIV Infections; HIV-1; Hospitalization; Humans; Infant; Infant Mortality; Infant, Low Birth Weight; Infant, Newborn; Infectious Disease Transmission, Vertical; Mothers; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; South Africa; Tuberculosis; Young Adult; Zidovudine

2018
Time trends of baseline demographics and clinical characteristics of HIV infected children enrolled in care and treatment service in Dar es Salaam, Tanzania.
    BMC infectious diseases, 2015, Mar-26, Volume: 15

    Topics: Adolescent; Age Distribution; Alkynes; Ambulatory Care Facilities; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Child; Child, Preschool; Comorbidity; Cyclopropanes; Female; HIV Infections; Humans; Infant; Lamivudine; Linear Models; Male; Nevirapine; Severity of Illness Index; Tanzania; Tuberculosis; Zidovudine

2015
CYP2B6 genotype-based efavirenz dose recommendations during rifampicin-based antituberculosis cotreatment for a sub-Saharan Africa population.
    Pharmacogenomics, 2016, Volume: 17, Issue:6

    Topics: Adult; Africa South of the Sahara; Alkynes; Anti-HIV Agents; Antitubercular Agents; Benzoxazines; Coinfection; Cyclopropanes; Cytochrome P-450 CYP2B6; Female; Genotype; HIV Infections; HIV-1; Humans; Lamivudine; Male; Reverse Transcriptase Inhibitors; Rifampin; Tuberculosis; Viral Load; Zidovudine

2016
Second-line treatment in the Malawi antiretroviral programme: high early mortality, but good outcomes in survivors, despite extensive drug resistance at baseline.
    HIV medicine, 2010, Volume: 11, Issue:8

    Topics: Adenine; Adolescent; Adult; Anti-Retroviral Agents; Body Mass Index; CD4 Lymphocyte Count; Developing Countries; Drug Resistance, Viral; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Genotype; HIV Infections; HIV-1; Humans; Malawi; Male; Medication Adherence; Middle Aged; National Health Programs; Organophosphonates; Prospective Studies; RNA, Viral; Statistics as Topic; Tenofovir; Treatment Failure; Tuberculosis; Urban Population; Viral Load; Zidovudine

2010
Drugs for AIDS and associated infections.
    The Medical letter on drugs and therapeutics, 1995, Oct-13, Volume: 37, Issue:959

    Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antiprotozoal Agents; Antiviral Agents; Atovaquone; Candidiasis, Oral; Clindamycin; Clotrimazole; Cryptosporidiosis; Cytomegalovirus Infections; Dapsone; Didanosine; Drug Combinations; Drug Therapy, Combination; Fluconazole; Flucytosine; Folic Acid Antagonists; Foscarnet; Glucuronates; Herpes Simplex; Herpes Zoster; Humans; Isoniazid; Itraconazole; Ketoconazole; Lamivudine; Mycobacterium avium-intracellulare Infection; Naphthoquinones; Nystatin; Pentamidine; Pneumocystis Infections; Pneumonia, Pneumocystis; Prednisone; Primaquine; Reverse Transcriptase Inhibitors; Stavudine; Syphilis; Toxoplasmosis; Trimetrexate; Tuberculosis; Zalcitabine; Zidovudine

1995
[Tuberculosis and AIDS in Paraguay].
    Boletin de la Oficina Sanitaria Panamericana. Pan American Sanitary Bureau, 1995, Volume: 118, Issue:3

    Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Age Factors; Antitubercular Agents; Cross-Sectional Studies; Drug Resistance, Microbial; Female; HIV Infections; Humans; Male; Middle Aged; Mycobacterium tuberculosis; Paraguay; Sex Factors; Tuberculosis; Zidovudine

1995
Pharmacokinetic interaction between rifampin and zidovudine.
    Antimicrobial agents and chemotherapy, 1993, Volume: 37, Issue:7

    Topics: Adult; Dose-Response Relationship, Drug; Drug Interactions; Humans; Male; Middle Aged; Rifampin; Tuberculosis; Zidovudine

1993
AIDS in Africans living in London.
    Genitourinary medicine, 1995, Volume: 71, Issue:6

    Topics: Acquired Immunodeficiency Syndrome; Adult; Africa; Antiviral Agents; Female; HIV Infections; Humans; London; Male; Middle Aged; Pneumonia, Pneumocystis; Retrospective Studies; Tuberculosis; Zidovudine

1995
Scientific world belatedly recognizes HIV risks to laboratorians.
    MLO: medical laboratory observer, 1992, Volume: 24, Issue:10

    Topics: Centers for Disease Control and Prevention, U.S.; HIV Infections; Humans; Laboratory Infection; Medical Laboratory Personnel; Needlestick Injuries; Occupational Exposure; Protective Devices; Risk Factors; Tuberculosis; United States; United States Occupational Safety and Health Administration; Zidovudine

1992
AIDS incidence and survival in a hospital-based cohort of asymptomatic HIV seropositive patients in São Paulo, Brazil.
    International journal of epidemiology, 1999, Volume: 28, Issue:6

    Topics: Acquired Immunodeficiency Syndrome; Adult; Age Distribution; Aged; AIDS-Related Opportunistic Infections; Antiviral Agents; Brazil; CD4 Lymphocyte Count; Cohort Studies; Disease Progression; Disease-Free Survival; Female; Follow-Up Studies; HIV Seropositivity; Hospitals, University; Humans; Incidence; Male; Middle Aged; Pneumonia, Pneumocystis; Risk-Taking; Sex Distribution; Survival Rate; Tuberculosis; Zidovudine

1999
Medical advances with international impact.
    AIDS treatment news, 1998, Mar-06, Issue:No 290

    Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antibiotics, Antitubercular; Antitubercular Agents; Clinical Trials as Topic; Developing Countries; Drug Therapy, Combination; Female; Health Services Accessibility; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Isoniazid; Pregnancy; Pregnancy Complications, Infectious; Pyrazinamide; Reagent Kits, Diagnostic; Rifampin; RNA, Viral; Tuberculosis; Viral Load; Zidovudine

1998
Combined toxicity of zidovudine and antituberculosis chemotherapy.
    The American review of respiratory disease, 1992, Volume: 145, Issue:2 Pt 1

    Topics: Adult; Antitubercular Agents; CD4 Antigens; Drug Interactions; Female; HIV Infections; Humans; Male; T-Lymphocyte Subsets; Tuberculosis; Zidovudine

1992
Primary care for patients with human immunodeficiency virus (HIV) infection in a methadone maintenance treatment program.
    Annals of internal medicine, 1989, Nov-01, Volume: 111, Issue:9

    Topics: Acquired Immunodeficiency Syndrome; Adult; Aerosols; Female; HIV Infections; Humans; Male; Methadone; New York City; Pentamidine; Pneumonia, Pneumocystis; Primary Health Care; Substance Abuse, Intravenous; Tuberculosis; Zidovudine

1989